Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.
UCLH has recruited the first patient to a trial that will look at whether giving blood plasma to patients hospitalised with severe Covid-19 infection can reduce illness severity and mortality.
UCLH is the first site to recruit a patient to a national urgent public health study analysing viral genomic data in real time to reduce the spread of Covid-19 in hospitals.
Researchers have identified an immune response detectable in the blood of patients with Covid-19 that could be used to determine whether a patient with the virus will develop severe lung complications.
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
A feature in The Lancet Respiratory Medicine has shone a spotlight on the experience of the UCLH and UCL team that worked with Mercedes F1 engineers to develop a life-saving breathing aid at the height of the pandemic.
A study supported by the NIHR UCLH Biomedical Research Centre carried out at UCL has found that people who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life.
